Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Nutt

Showing results (51-60 of 389) with videos related to

Pageof 39
Sort By:
Pharmacology, Biochemistry, and Behavior|May 20, 2008
GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety?Jayne E Bailey, David J Nutt
Depression and Anxiety|November 23, 2006
Role of GABA in anxiety and depressionAllan V Kalueff, David J Nutt
Lancet (London, England)|March 18, 2014
Deaths from "legal highs": a problem of definitionsLeslie A King, David J Nutt,
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 22, 2012
On assessing potential efficacy for vortioxetine in generalized anxiety disorderDavid S Baldwin, David J Nutt
Nature Medicine|May 25, 2021
Putting the MD back into MDMADavid J Nutt, Harriet de Wit
European Addiction Research|September 25, 2024
Psychedelics: From Cave Art to 21st-Century Medicine for AddictionIoanna A Vamvakopoulou, David J Nutt
The Lancet. Psychiatry|August 29, 2016
Question-based Drug Development for psilocybin - Authors' replyRobin L Carhart-Harris, David J Nutt
Current Opinion in Pharmacology|January 22, 2005
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorderKevin C F Fone, David J Nutt
Journal of Studies on Alcohol and Drugs|March 22, 2024
A Perspective on Psychedelics as Treatments for AddictionsDavid J Nutt, Celia Morgan, Sukhpreet Klaire
International Journal of Tryptophan Research : IJTR|November 16, 2011
Tryptophan research in panic disorderEduard Maron, Jakov Shlik, David J Nutt
Pageof 39

Showing results (51-60 of 389) with videos related to

Sort By:
Pageof 39
Pharmacology, Biochemistry, and Behavior|May 20, 2008
GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety?Jayne E Bailey, David J Nutt
Depression and Anxiety|November 23, 2006
Role of GABA in anxiety and depressionAllan V Kalueff, David J Nutt
Lancet (London, England)|March 18, 2014
Deaths from "legal highs": a problem of definitionsLeslie A King, David J Nutt,
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 22, 2012
On assessing potential efficacy for vortioxetine in generalized anxiety disorderDavid S Baldwin, David J Nutt
Nature Medicine|May 25, 2021
Putting the MD back into MDMADavid J Nutt, Harriet de Wit
European Addiction Research|September 25, 2024
Psychedelics: From Cave Art to 21st-Century Medicine for AddictionIoanna A Vamvakopoulou, David J Nutt
The Lancet. Psychiatry|August 29, 2016
Question-based Drug Development for psilocybin - Authors' replyRobin L Carhart-Harris, David J Nutt
Current Opinion in Pharmacology|January 22, 2005
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorderKevin C F Fone, David J Nutt
Journal of Studies on Alcohol and Drugs|March 22, 2024
A Perspective on Psychedelics as Treatments for AddictionsDavid J Nutt, Celia Morgan, Sukhpreet Klaire
International Journal of Tryptophan Research : IJTR|November 16, 2011
Tryptophan research in panic disorderEduard Maron, Jakov Shlik, David J Nutt
Pageof 39